COVID - 19

Croatian Journal of Infection

Gold Open Acess - NO PUBLICATION FEE

Peer-Reviewed Journal

Croatian Journal of Infection (CJI) is a journal in the field of infectious disease and clinical microbiology with a broad international readership. The Journal publishes articles on a variety of subjects of interest to practitioners and researchers. Topics range from clinical descriptions of infections, public health, microbiology, and immunology to the prevention of infection, the evaluation of current and novel treatments, and the promotion of optimal practices for diagnosis and treatment. The Journal publishes original research, editorials, review articles, viewpoints, book reviews, case reports and images in infectious diseases and clinical microbiology. Croatian Journal of Infection (CJI) is an official publication of the Croatian Society for Infectious Diseases of the Croatian Medical Association and University Hospital for Infectious Diseases in collaboration with Croatian Society for Clinical Microbiology of the Croatian Medical Association.

What’s New in ID July-August 2020. – Srpanj-Kolovoz 2020.

Author: Marija Kusulja, MD Time to Antibiotic for Pediatric Oncology Patients With Febrile Neutropenia at Regional Emergency Departments This study evaluated time to antibiotic in 205 […]

What’s New in ID April-June 2020. – Travanj-Lipanj 2020.

What’s new in ID April 2020 – June 2020. Authors: Marija Kusulja, Vladimir Krajinović Association of a Care Bundle for Early Sepsis Management With Mortality […]

What’s New in ID February/March 2020. – Veljača/Ožujak 2020.

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England The United Kingdom introduced a meningococcal group B vaccine (4CMenB, Bexero) into the national immunization […]

What’s New in ID? January 2020 / Siječanj 2020.

The Effect of Infectious Diseases Consultation on Mortality in Hospitalized Patients With MRSA, Candida, and Pseudomonas Bloodstream Infections Abstract We evaluated the association between infectious […]

What’s New in ID? December 2019 / Prosinac 2019.

Clinical phenotypes in sepsis Clinical phenotypes have been proposed as a potential way to identify those most at risk of dying from sepsis. In a retrospective […]

What’s New in ID? October-November 2019 / Listopad-Studeni 2019.

Lefamulin for the treatment of community-acquired pneumonia Lefamulin is a novel antibiotic with activity against many common community-acquired pneumonia (CAP) pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and […]

What’s New in ID? September 2019 / Rujan 2019.

Antibiotic overuse and adverse events in patients with community-acquired pneumonia Several meta-analyses have shown that short-course antibiotic therapy (ie, 5 to 7 days) is as […]

What’s New in ID? July-August 2019 / Srpanj-Kolovoz 2019.

Chronic hepatitis B infections on the rise since 2008 News story 17 Jun 2019 In 2017, the majority (58%) of the almost 27 000 newly […]

What’s New in ID? June 2019 / Lipanj 2019.

IDSA guidelines on asymptomatic bacteriuria (June 2019) The Infectious Diseases Society of America recently released updated guidelines on asymptomatic bacteriuria, which include discussion of populations not […]

New Ebola cases in Uganda raise fears of further spread/June 2019

The current outbreak in the Democratic Republic of Congo has infected more than 2,000 people, killing at least 1,390 of them. Uganda announced two more […]

Linkovi

SUBMISSION